These data were in agreement with previous studies in other types of cancer, where ADAMTS-4 and -5 had been found to be over-expressed in order to degrade ECM proteoglycans, such as agreecan and versican to facilitate cancer cell invasion [24, 25]. This evidence concerns the gene ADAMTS4 and cancer.